TNK2
Summary: This gene encodes a tyrosine kinase that binds Cdc42Hs in its GTP-bound form and inhibits both the intrinsic and GTPase-activating protein (GAP)-stimulated GTPase activity of Cdc42Hs. This binding is mediated by a unique sequence of 47 amino acids C-terminal to an SH3 domain. The protein may be involved in a regulatory mechanism that sustains the GTP-bound active form of Cdc42Hs and which is directly linked to a tyrosine phosphorylation signal transduction pathway. Several alternatively spliced transcript variants have been identified from this gene, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
tyrosine kinase non receptor 2 | MIM:606994 | Ensembl:ENSG00000061938 | HGNC:HGNC:19297 | PA134909759 | 3q29 |
GO terms in TNK2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IEA | GO:0006897 | endocytosis |
BP | TAS | GO:0007166 | cell surface receptor signaling pathway |
BP | IBA | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway |
BP | TAS | GO:0007264 | small GTPase mediated signal transduction |
BP | IDA | GO:0016310 | phosphorylation |
BP | IBA | GO:0030154 | cell differentiation |
BP | IEA | GO:0034260 | negative regulation of GTPase activity |
BP | IBA | GO:0038083 | peptidyl-tyrosine autophosphorylation |
BP | IBA | GO:0042127 | regulation of cell proliferation |
BP | IBA | GO:0045087 | innate immune response |
BP | IDA | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation |
BP | IDA | GO:2000369 | regulation of clathrin-dependent endocytosis |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005737 | cytoplasm |
CC | ISS | GO:0005768 | endosome |
CC | IDA | GO:0005886 | plasma membrane |
CC | IDA | GO:0005905 | clathrin-coated pit |
CC | IEA | GO:0005912 | adherens junction |
CC | HDA | GO:0016020 | membrane |
CC | IDA | GO:0030136 | clathrin-coated vesicle |
CC | IEA | GO:0030659 | cytoplasmic vesicle membrane |
CC | IBA | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane |
CC | IEA | GO:0048471 | perinuclear region of cytoplasm |
CC | IDA | GO:0070436 | Grb2-EGFR complex |
MF | IEA | GO:0004674 | protein serine/threonine kinase activity |
MF | IDA | GO:0004712 | protein serine/threonine/tyrosine kinase activity |
MF | IDA | GO:0004713 | protein tyrosine kinase activity |
MF | IBA | GO:0004715 | non-membrane spanning protein tyrosine kinase activity |
MF | TAS | GO:0005095 | GTPase inhibitor activity |
MF | IBA | GO:0005102 | signaling receptor binding |
MF | IDA | GO:0005154 | epidermal growth factor receptor binding |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IPI | GO:0031625 | ubiquitin protein ligase binding |
MF | IPI | GO:0042802 | identical protein binding |
MF | IEA | GO:0046872 | metal ion binding |
MF | ISS | GO:0050699 | WW domain binding |
Gene expression in normal tissue: TNK2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in TNK2
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP306 | Focal Adhesion |
wikipathways | WP3941 | Oxidative Damage |
wikipathways | WP437 | EGF-EGFR Signaling Pathway |
wikipathways | WP524 | G13 Signaling Pathway |
pid | cdc42_pathway | CDC42 signaling events |
netpath | Pathway_EGFR1 | EGFR1 |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD405 | PIK-75 | 2 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
iGMDRD512 | nutlin 3 | 2 |
iGMDRD123 | Isoevodiamine | 2 |
iGMDRD237 | ABT-751 | 5 |
iGMDRD314 | Tanespimycin | 2 |
iGMDRD57 | Chloropentafluorobenzene | 3 |
iGMDRD351 | GW843682X | 4 |
iGMDRD415 | LE-135 | 2 |
iGMDRD289 | Parthenolide | 2 |
iGMDRD6 | AM-580 | 1 |
iGMDRD105 | Triptolide | 2 |
iGMDRD5 | Tyrphostin AG 1478 | 2 |
iGMDRD137 | Indisulam | 12 |
iGMDRD202 | Curcumin | 4 |
iGMDRD103 | SN-38 | 5 |
iGMDRD82 | Quiflapon | 1 |
iGMDRD246 | NPC26 | 2 |
iGMDRD505 | Pevonedistat | 3 |
iGMDRD483 | SCH-529074 | 1 |
iGMDRD494 | Neopeltolide | 2 |
iGMDRD1008 | SR-II-138A | 3 |
iGMDRD772 | BRD4770 | 2 |
iGMDRD425 | ERASTIN | 2 |
iGMDRD634 | SCHEMBL2608041 | 2 |
iGMDRD375 | GW-405833 | 1 |
iGMDRD679 | Bistramide A | 2 |
iGMDRD394 | BX-795 | 1 |
iGMDRD280 | CYTOCHALASIN B | 1 |
iGMDRD466 | Chaetocin | 3 |
iGMDRD2 | PK-11195 | 2 |
iGMDRD152 | 179324-69-7 | 2 |
iGMDRD193 | Fqi1 | 4 |
iGMDRD316 | N9-Isopropyl-olomoucine | 1 |
iGMDRD446 | LY 2183240 | 1 |
iGMDRD294 | Batimastat | 2 |
iGMDRD870 | BRD63610 | 2 |
iGMDRD171 | Pemetrexed | 6 |
iGMDRD802 | 4-methylfasudil | 2 |
iGMDRD474 | Avrainvillamide | 2 |
iGMDRD513 | BML-259 | 2 |
iGMDRD524 | ISX-9 | 5 |
iGMDRD356 | PNU-74654 | 2 |
iGMDRD60 | Quinoclamine | 3 |
iGMDRD64 | Parbendazole | 4 |
iGMDRD562 | Navitoclax | 2 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD399 | Selumetinib | 3 |
iGMDRD74 | Idarubicin | 5 |
iGMDRD188 | Piperlongumine | 5 |
iGMDRD100 | Zebularine | 4 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in TNK2